Attached files
| file | filename |
|---|---|
| EX-99.1 - Xtant Medical Holdings, Inc. | v209694_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): February 1, 2011
Bacterin
International Holdings, Inc.
|
(Exact
Name of Registrant as Specified in Its Charter)
|
|
|
Delaware
|
|
|
(State
or Other Jurisdiction of Incorporation)
|
|
|
333-158426
|
20-5313323
|
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
600
Cruiser Lane
Belgrade,
Montana
|
59714
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
(406)
388-0480
|
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions (see
General Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01 Regulation
FD Disclosure.
A copy of Bacterin’s most recent
investor presentation is attached as Exhibit 99.1 and incorporated
herein. Bacterin plans to use the attached presentation in meetings
with potential investors in February 2011, including meetings at the Lazard
Capital Markets 3rd Annual Medical Technology & Life
Science Tools Snowbird Conference, February 23-25, 2011, at the Cliff Lodge,
Snowbird Ski & Summer Resort, Snowbird, Utah. The information in
this Item 7.01 and the document attached as Exhibit 99.1 are being furnished and
shall not be deemed “filed” for purposes of Section 18 of the Securities and
Exchange Act of 1934, as amended (the “Exchange Act”), nor otherwise subject to
the liabilities of that section, nor incorporated by reference in any filing
under the Securities Act of 1933 or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.
This Form
8-K contains forward-looking statements that are subject to various assumptions,
risks and uncertainties. These forward-looking statements include
earnings guidance and other statements regarding our expectations and
beliefs. The Company believes that its expectations, as expressed in
these statements are based on reasonable assumptions regarding the risks and
uncertainties inherent in achieving those expectations. These
statements are not, however, guarantees of performance and actual results may
differ materially. Risks and uncertainties which may cause actual
results to be different than expressed or implied in our forward-looking
statements include, but are not limited to, the risk factors described under the
heading “Risk Factors” in Amendment No. 2 to our Form S-1 filed January 7,
2011. The Company expressly disclaims any current intention to update
any forward-looking statements as a result of new information or future events
or developments.
Item 9.01. Financial Statements and
Exhibits.
(d) Exhibits.
|
Exhibit
No
|
Description
|
|
|
99.1
|
Bacterin
International Holdings, Inc. Investor Presentation February
2011
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| Dated: February 1, 2011 | BACTERIN INTERNATIONAL HOLDINGS, INC. | ||
|
|
By:
|
/s/ Guy S. Cook | |
|
Name: Guy
S. Cook
Title: President
and Chief Executive Officer
|
|||